Blinatumomab is associated with significantly higher event-free survival among children with newly diagnosed high-risk B-cell acute lymphoblastic leukemia (ALL), according to a study published in the Sept. 17 issue of the New England Journal of Medicine.
CU Anschutz thyroid cancer researchers get major boost from DOD Impact Award EurekAlert!
Which Is the Bigger Story for BioNTech -- Its Colorectal Cancer Vaccine Setback or the Lung Cancer Clinical Success? The Motley Fool
Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial Nature
Study Unveils ‘Plug-and-Play’ CAR T Technology Designed to Adapt as Cancer Changes businesswire.com
Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study Nature
A Family with Deep CU Ties Supports a Home-Grown Study Seeking a Better Leukemia Treatment University of Colorado Anschutz
PATHFINDER 2 findings advance multi-cancer early detection blood testing OHSU News
Generic drug shows promise easing hot flashes from prostate cancer therapy foxcarolina.com
For patients receiving immune checkpoint inhibitors (ICIs), rheumatic immune-related adverse events (rh-irAEs) are usually moderate or severe, with more than one-third leading to permanent ICI discontinuation, according to a study published online Sept. 8 in ACR Open Rheumatology.
U.S. Cancer Mortality Declined 35% Since 1991, AACR Report Shows MedPage Today
Doctor Faced with Cancer Diagnosis Honored by San Diego Padres health.ucsd.edu
Local Treatment of the Primary Tumor in Metastatic Bladder Cancer After Exceptional Response - Ananya Choudhury & Alexandra Masson-Lecomte urotoday.com
Ovarian Cancer PFS Improves With Treatment Combo Physician's Weekly